Brookstone Capital Management

Position in HROW — Harrow, Inc.

CIK 1599584 WHEATON, IL

Position in HROW

as of Mar 31, 2026 · filed Apr 16, 2026 Compact

Position Value

$1,018,449

-$1,186,990 QoQ

Shares Held

28,884

-36.9% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

5 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Brookstone Capital Management holds $4,588,273 across 4 Drug Manufacturers - Specialty & Generic names. HROW ranks #2 (22.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	4,471	$2,651,213
2	HROW	Harrow, Inc. This page	28,884	$1,018,449
3	NBIX	Neurocrine Biosciences Inc	5,050	$665,287
4	ZTS	Zoetis Inc.	2,143	$253,324

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,018,449	28,884	-36.9%	Shares	Sole	2026-04-16
2025-09-30	$2,205,439	45,775	+232.5%	Shares	Sole	2025-10-15
2025-06-30	$420,413	13,766	+12.3%	Shares	Sole	2025-07-30
2025-03-31	$325,956	12,254	+49.7%	Shares	Sole	2025-04-29
2024-12-31	$274,707	8,188	—	Shares	Sole	2025-01-13
No filing history on record for this holder in this stock.